Bailard’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$193K Hold
24,624
– – ﹤0.01% 722
2026
Q2
$160K Buy
+24,624
New +$118K ﹤0.01% 745
2020
Q1
– Sell
-11,816
Closed -$61K – 473
2019
Q4
$61K Hold
11,816
– – ﹤0.01% 533
2019
Q3
$70K Sell
11,816
-2,700
-19% -$15K ﹤0.01% 523
2019
Q2
$92K Buy
+14,516
New +$88K 0.01% 531

Bailard's CPIX Position: Q3 2026 in Review

Bailard held its Cumberland Pharmaceuticals (CPIX) position steady in Q3 2026 at 24,624 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Bailard first reported a position in CPIX in Q2 2019 and has held it in 5 quarters since. 1 fund tracked by Wall St. Rank holds CPIX as of Q3 2026.

  • Bailard held 24,624 shares of Cumberland Pharmaceuticals worth $193K as of Q3 2026.
  • Bailard left its Cumberland Pharmaceuticals share count unchanged in Q3 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Bailard's portfolio in Q3 2026, its #722 holding.
  • Bailard first reported a position in Cumberland Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
  • 1 fund tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.